-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
While the global outbreak of COVID-19 (also known as the new crown) has not yet ended, monkeypox (Monkeypox) has also been included in the World Health Organization (WHO) "Public Health Emergency" (PHEIC) list
The case report was published in the Journal of Infection, a British medical journal
From June 16 to June 20 this year, a 36-year-old Italian man stayed in Spain for five days
After returning to Italy, he developed a fever (39°C) with symptoms such as sore throat, fatigue, headache and swollen lymph nodes in the right groin
On July 6, it was officially diagnosed as a patient with Covid-19 and monkeypox (Monkeypox).
The case report also said that when admitted to hospital for treatment, the Italian man admitted that he had been treated for Syphilis in 2019
In December 2021, the man received two doses of the BNT162b2 mRNA vaccine made by Pfizer
Ultimately, the man was also diagnosed with the AIDS virus (HIV), becoming the first confirmed case in the world to have COVID-19, monkeypox and AIDS at the same time
According to the case report, the case of the Italian man showed that 1) humans can be infected with both male monkeypox virus and SARS-CoV-2; 2) people with flu-like symptoms and a positive COVID-19 nucleic acid test should not be taken from people at high risk of monkeypox.
Our case highlights that sexual intercourse may be the primary mode of transmission
Original source:
First case of monkeypox virus, SARS-CoV-2 and HIV co-infection, #%20
